|
 |
|
| Home > In Vitro Diagnostics |
| |
| |
|
| |
 In Vitro Diagnostics Market Research Reports |
2016 Lithuania Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.
|
 |
|
$4250.00 |
| |
|
|
|
2016 Malta Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.
|
|
|
$4250.00 |
| |
|
|
|
2016 Netherlands Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.
|
|
|
$4250.00 |
| |
|
|
|
2016 Norway Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.
|
|
|
$4250.00 |
| |
|
|
|
2016 Poland Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.
|
|
|
$4250.00 |
| |
|
|
|
2016 Portugal Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.
|
|
|
$4250.00 |
| |
|
|
|
2016 Romania Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.
|
|
|
$4250.00 |
| |
|
|
|
2016 Slovakia Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.
|
|
|
$4250.00 |
| |
|
|
|
2016 Slovenia Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.
|
|
|
$4250.00 |
| |
|
|
|
2016 Sweden Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.
|
|
|
$4250.00 |
| |
|
|
|
2016 Switzerland Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.
|
|
|
$4250.00 |
| |
|
|
|
2023 Europe Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers
This unique report from VPGMarketResearch provides Europe sales and market share estimates for major suppliers of molecular diagnostic products by country.The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
|
|
|
$4200.00 |
| |
|
|
|
US Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country
This unique report from Venture Planning Group provides US sales and market share estimates for major suppliers of cancer diagnostic testing products by assay and country.The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
|
|
|
$4000.00 |
| |
|
|
|
Analysis of the European HIV/AIDS Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs--
Supplier Shares and Sales Forecasts For Immunodiagnostic
and NAT Procedures
This 5-country report presents detailed analyses of the AIDS diagnostics market in Europe (France, Germany, Italy, Spain, UK). For each country, the report provides test volume and sales forecasts for HIV-1/2, HIV Ag, NAT, Western Blot and other confirmatory tests performed in the following market segments:
|
|
|
$3950.00 |
| |
|
|
|
Analysis of Emerging Immunodiagnostic Tests, and Strategic Profiles of Leading Suppliers
This 240-page report presents an overview of the clinical significance and market needs for major Chemistry, TDM, Endocrine, Cancer, Immunoprotein, and Abused Drug assays, including listings of companies developing or marketing new technologies and products.
|
|
|
$3950.00 |
| |
|
|
|
Immunodiagnostic Tests, and Strategic Profiles of Leading Reagent and Instrument Suppliers
This report presents an overview of the clinical significance and market needs for major Chemistry, TDM, Endocrine, Cancer, Immunoprotein, and Abused Drug assays, including listings of companies developing or marketing new technologies and products.
|
|
|
$3950.00 |
| |
|
|
|
Europe Sales and Market Shares of Major Coagulation Reagent and Instrument Suppliers by Country
This unique report from Venture Planning Group provides European sales and market share estimates for major suppliers of coagulation reagents and instruments by country.The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
|
|
|
$3900.00 |
| |
|
|
|
Analysis of the US Hepatitis Diagnostics Market:
Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures
The report presents a detailed analysis of the Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:
|
|
|
$3900.00 |
| |
|
|
|
|